Lian Duan
-
- Pituitary Gland Disorders and Treatments 43
- Growth Hormone and Insulin-like Growth Factors 40
- Genetics top 10%
- Glioma Diagnosis and Treatment 12
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 20
- Hepatology top 10%
-
- Adrenal and Paraganglionic Tumors 24
-
- Neuroendocrine Tumor Research Advances 6
-
- Lipid metabolism and disorders 6
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lian Duan
139 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Endocrinology, Diabetes and Metabolism 289
- Genetics 130
- Cancer Research 174
- Oncology 266
- Hepatology 77
Countries citing papers authored by Lian Duan
This map shows the geographic impact of Lian Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian Duan more than expected).
Fields of papers citing papers by Lian Duan
This network shows the impact of papers produced by Lian Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian Duan. The network helps show where Lian Duan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lian Duan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 29 | |
| 17 | 2019 | 19 | |
| 18 | 2015 | 0 | |
| 19 | 2013 | 15 | |
| 20 | Genotoxic studies on Panax ginseng and Polygonum multiflorum and their combination in mouse peripheral lymphocyte cells | 2007 | 1 |
About Lian Duan
Lian Duan is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Cancer Research, having authored 160 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (43 papers), Growth Hormone and Insulin-like Growth Factors (40 papers), Adrenal and Paraganglionic Tumors (24 papers), Cancer Immunotherapy and Biomarkers (20 papers), Glioma Diagnosis and Treatment (12 papers), Neuroendocrine Tumor Research Advances (6 papers), Lipid metabolism and disorders (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (289 citations), Genetics (130 citations) and Cancer Research (174 citations). Lian Duan has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jingyu Yang, Chun Fu Wu, Huijuan Zhu, Hanping Wang, Xiaoyan Si, Xiaoxiao Guo, Jiaxin Zhou, Kikuo Ohno, Linjie Wang and Masashi Tamaki.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.